Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 14/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 7/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | RORC | P51449 | 2/20 | 0.39 |
| ▸ | SFRP1 | Q8N474 | 1/20 | 0.39 |
| ▸ | RHOC | P08134 | 1/20 | 0.37 |
| ▸ | RHOA | P61586 | 1/20 | 0.37 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3026452 | 0.82 | CACNA1B (0.58) | CACNA1BNR1I2CYP3A4RORCSFRP1 | |
| SCHEMBL3035955 | 0.78 | CACNA1B (0.67) | CACNA1BNR1I2CYP3A4SFRP1 | |
| SCHEMBL3126273 | 0.76 | CACNA1B (0.58) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3138330 | 0.74 | CACNA1B (0.58) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3126830 | 0.73 | CACNA1B (0.44) | CACNA1BNR1I2CYP3A4SLC6A9 | |
| SCHEMBL3041075 | 0.73 | CACNA1B (0.63) | CACNA1BNR1I2CYP3A4SFRP1 | |
| SCHEMBL3135768 | 0.72 | CACNA1B (0.46) | CACNA1BNR1I2CYP3A4SLC6A9 | |
| SCHEMBL3038967 | 0.72 | CACNA1B (0.56) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3136127 | 0.72 | CACNA1B (0.50) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3030681 | 0.71 | CACNA1B (0.64) | CACNA1BNR1I2CYP3A4SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2205083-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2010-07-14 | — | — | EP | claimed |
| WO-2009045382-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK & CO., INC. (US) | 2009-04-09 | — | — | WO | claimed |